| 00:00 - 23:59 | 3 | The changing and challenging landscape of the global tobacco epidemic: from vaping to cannabis? | Hot topics |
| 00:00 - 23:59 | 4 | Teaching, learning and assessments: key principles | Professional development |
| 00:00 - 23:59 | 5 | Medical writing | Professional development |
| 00:00 - 23:59 | 6 | Leading and managing change | Professional development |
| 00:00 - 23:59 | 7 | How to deal with difficult people | Professional development |
| 00:00 - 23:59 | 8 | Teamability: becoming an effective team leader and member | Professional development |
| 00:00 - 23:59 | 9 | Clinical year in review | Year in review |
| 00:00 - 23:59 | 10 | Scientific year in review | Year in review |
| 00:00 - 23:59 | 11 | Paediatric year in review | Year in review |
| 00:00 - 23:59 | 12 | Do we really need guidelines? | Expert view |
| 00:00 - 23:59 | 13 | CRISPR for dummies | Expert view |
| 00:00 - 23:59 | 14 | Microplastic in the lungs: should we be worried? | Expert view |
| 00:00 - 23:59 | 15 | Puzzling natures of the solitary pulmonary nodules that only the pulmonologist can solve | Expert view |
| 00:00 - 23:59 | 16 | Transbronchial cryobiopsy in diffuse parenchymal lung diseases | Expert view |
| 00:00 - 23:59 | 17 | The role of the radiologist in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis | Expert view |
| 00:00 - 23:59 | 18 | Managing stable, severe COPD | Expert view |
| 00:00 - 23:59 | 19 | Bronchoscopy interventions in ventilated patients | Expert view |
| 00:00 - 23:59 | 20 | Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis | Expert view |
| 00:00 - 23:59 | 22 | Successfully managing adolescent and young adult patients with asthma | Expert view |
| 00:00 - 23:59 | 23 | Extracorporeal life support in lung failure and lung transplant bridging: when and how | Expert view |
| 00:00 - 23:59 | 24 | Physiotherapy in chronic respiratory infections | Expert view |
| 00:00 - 23:59 | 25 | Optimal treatment for multistage N2-disease | Expert view |
| 00:00 - 23:59 | 26 | From life threatening to chronic connective tissue disease-associated interstitial lung disease (CTD-ILD): all you need to know | Expert view |
| 00:00 - 23:59 | 27 | Treatment in pulmonary hypertension | Expert view |
| 00:00 - 23:59 | 28 | Burning up while burning out: compassion fatigue awareness and burnout prevention for practitioners | Expert view |
| 00:00 - 23:59 | 29 | AI: are the doctors still needed? | Expert view |
| 00:00 - 23:59 | 30 | Common variable immunodeficiency (CVID) | Expert view |
| 00:00 - 23:59 | 31 | Gender-based differences in drug toxicity | Expert view |
| 00:00 - 23:59 | 32 | The role of patients in medicine | Expert view |
| 00:00 - 23:59 | 33 | Genom revolution: Human Lung Cell Atlas | Expert view |
| 00:00 - 23:59 | 34 | Aspects of pulmonary rehabilitation: part 2 | E-poster session |
| 00:00 - 23:59 | 35 | Reviews and novel insights into pulmonary rehabilitation | E-poster session |
| 00:00 - 23:59 | 36 | Diagnosis and management of COPD | E-poster session |
| 00:00 - 23:59 | 37 | Air pollution and comorbidities | E-poster session |
| 00:00 - 23:59 | 38 | Lung function tests and exhaled biomarkers | E-poster session |
| 00:00 - 23:59 | 39 | Unusual tools for evaluating obstructive diseases | E-poster session |
| 00:00 - 23:59 | 40 | Clinical and basic pharmacology for COPD | E-poster session |
| 00:00 - 23:59 | 41 | Clinical characteristics and diagnostic tools for phenotyping asthma and COPD | E-poster session |
| 00:00 - 23:59 | 42 | Prevalence, characteristics and predictors of obstructive sleep apnoea | E-poster session |
| 00:00 - 23:59 | 43 | Management of allergy, asthma and COPD | E-poster session |
| 00:00 - 23:59 | 44 | Physical activity and chronic lung disease | E-poster session |
| 00:00 - 23:59 | 45 | Exercise tolerance and functional status across respiratory diseases | E-poster session |
| 00:00 - 23:59 | 46 | Pulmonary hypertension in lung diseases | E-poster session |
| 00:00 - 23:59 | 47 | New insight into the immunology of asthma and COPD | E-poster session |
| 00:00 - 23:59 | 48 | Chronic lung diseases: novel methods, diagnostics and biomarkers | E-poster session |
| 00:00 - 23:59 | 49 | Novel findings in intensive care unit medicine: part 2 | E-poster session |
| 00:00 - 23:59 | 50 | Clinical monitoring and new therapies for cystic fibrosis | E-poster session |
| 00:00 - 23:59 | 51 | Home non-invasive ventilation: (long-term) effects and prognosis | E-poster session |
| 00:00 - 23:59 | 52 | Pulmonary function and rehabilitation in non-respiratory disease | E-poster session |
| 00:00 - 23:59 | 53 | Risk factors, comorbidities and remote monitoring in childhood asthma | E-poster session |
| 00:00 - 23:59 | 54 | Determinants of chronic respiratory diseases | E-poster session |
| 00:00 - 23:59 | 55 | Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more | E-poster session |
| 00:00 - 23:59 | 56 | Multidrug-resistant tuberculosis | E-poster session |
| 00:00 - 23:59 | 57 | Tuberculosis and comorbidities | E-poster session |
| 00:00 - 23:59 | 58 | Tuberculosis and adverse events in different populations | E-poster session |
| 00:00 - 23:59 | 59 | Diagnostic challenges in tuberculosis | E-poster session |
| 00:00 - 23:59 | 60 | Clinical and functional evaluation of COPD | E-poster session |
| 00:00 - 23:59 | 61 | Mechanistic insight into lung injury and repair | E-poster session |
| 00:00 - 23:59 | 62 | Challenges and updates in nursing care around the world | E-poster session |
| 00:00 - 23:59 | 63 | Cellular stress in respiratory diseases | E-poster session |
| 00:00 - 23:59 | 64 | Novel molecular markers and targets for asthma phenotypes | E-poster session |
| 00:00 - 23:59 | 65 | Inhaler devices in COPD: technical advances, adherence studies and more | E-poster session |
| 00:00 - 23:59 | 66 | Occupational exposure as a cause of respiratory disease | E-poster session |
| 00:00 - 23:59 | 67 | Paediatric asthma | E-poster session |
| 00:00 - 23:59 | 68 | Microbiology and antimicrobial strategies in cystic fibrosis | E-poster session |
| 00:00 - 23:59 | 69 | The multiple facets of pulmonary rehabilitation and chronic respiratory care | E-poster session |
| 00:00 - 23:59 | 70 | Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis | E-poster session |
| 00:00 - 23:59 | 71 | Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment | E-poster session |
| 00:00 - 23:59 | 72 | Clinical aspects of idiopathic pulmonary fibrosis | E-poster session |
| 00:00 - 23:59 | 73 | News on diagnosis and therapy of idiopathic pulmonary fibrosis | E-poster session |
| 00:00 - 23:59 | 74 | Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis | E-poster session |
| 00:00 - 23:59 | 75 | Prognosis and biomarkers of idiopathic pulmonary fibrosis | E-poster session |
| 00:00 - 23:59 | 76 | Pulmonary rehabilitation across the globe | E-poster session |
| 00:00 - 23:59 | 77 | New imaging techniques applied to old problems | E-poster session |
| 00:00 - 23:59 | 78 | Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema | E-poster session |
| 00:00 - 23:59 | 79 | Optimising the benefits of pulmonary rehabilitation | E-poster session |
| 00:00 - 23:59 | 80 | Inflammatory pathways in chronic airway diseases | E-poster session |
| 00:00 - 23:59 | 81 | Exploring exercise responses in respiratory diseases | E-poster session |
| 00:00 - 23:59 | 82 | New insights into determinants of patient-reported outcomes in chronic respiratory diseases | E-poster session |
| 00:00 - 23:59 | 83 | Prediction of outcomes in obstructive diseases | E-poster session |
| 00:00 - 23:59 | 84 | Clinical studies of COPD: combination inhalers and much more | E-poster session |
| 00:00 - 23:59 | 85 | Clinical data and COPD management | E-poster session |
| 00:00 - 23:59 | 86 | Prognosis and integrated management of COPD | E-poster session |
| 00:00 - 23:59 | 87 | Evaluation of knowledge transfer into clinical practice | E-poster session |
| 00:00 - 23:59 | 88 | Monitoring of patients with COPD | E-poster session |
| 00:00 - 23:59 | 89 | Host-microbe interactions and their influence on lung disease onset and severity | E-poster session |
| 00:00 - 23:59 | 90 | Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases | E-poster session |
| 00:00 - 23:59 | 91 | Asthma management: role of biomarkers and comorbidities | E-poster session |
| 00:00 - 23:59 | 92 | Phenotypes of asthma and COPD | E-poster session |
| 00:00 - 23:59 | 93 | Asthma and COPD: How genetic and environment influences its developement? | E-poster session |
| 00:00 - 23:59 | 94 | Novel directions in pleural disease: bench to bedside | E-poster session |
| 00:00 - 23:59 | 95 | Different aspects of paediatric viral and bacterial lung infections | E-poster session |
| 00:00 - 23:59 | 96 | Respiratory physiology and sleep: new approaches to diagnosis and treatment | E-poster session |
| 00:00 - 23:59 | 97 | Interventional pulmonology: diagnostic and therapeutic approaches | E-poster session |
| 00:00 - 23:59 | 98 | Novel mechanisms and management of paediatric asthma | E-poster session |
| 00:00 - 23:59 | 99 | Respiratory physiology and sleep: what is new? | E-poster session |
| 00:00 - 23:59 | 100 | Phenotypes of obstructive diseases | E-poster session |
| 00:00 - 23:59 | 101 | New insights into respiratory physiotherapy | E-poster session |
| 00:00 - 23:59 | 102 | News on clinical evaluation of bronchiectasis, cough and inflammatory disease | E-poster session |
| 00:00 - 23:59 | 103 | Air pollution as a cause of respiratory disease | E-poster session |
| 00:00 - 23:59 | 104 | Smoking disease landscape: from inflammation to lung function and comorbidities | E-poster session |
| 00:00 - 23:59 | 105 | Pathophysiology and treatment of obstructive sleep apnoea | E-poster session |
| 00:00 - 23:59 | 106 | Digital health interventions in respiratory medicine | E-poster session |
| 00:00 - 23:59 | 107 | Epidemiology of tobacco use and the role of health professionals in tobacco control | E-poster session |
| 00:00 - 23:59 | 108 | Risk factors for chronic lung diseases | E-poster session |
| 00:00 - 23:59 | 109 | Clinical and laboratory pharmacology in asthma | E-poster session |
| 00:00 - 23:59 | 110 | Comorbidities/multimorbidites and mortality in patients with chronic lung diseases | E-poster session |
| 00:00 - 23:59 | 111 | Tuberculosis and society | E-poster session |
| 00:00 - 23:59 | 112 | Epidemiology and treatment of pulmonary arterial hypertension | E-poster session |
| 00:00 - 23:59 | 113 | Experimental approaches to pulmonary hypertension | E-poster session |
| 00:00 - 23:59 | 114 | Exercise and haemodynamics in pulmonary hypertension | E-poster session |
| 00:00 - 23:59 | 115 | Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension | E-poster session |
| 00:00 - 23:59 | 116 | Chronic thromboembolic pulmonary hypertension | E-poster session |
| 00:00 - 23:59 | 117 | The young, the old and extrapulmonary tuberculosis | E-poster session |
| 00:00 - 23:59 | 118 | Interventional pulmonology: unity in diversity | E-poster session |
| 00:00 - 23:59 | 119 | Multidrug-resistant tuberculosis | E-poster session |
| 00:00 - 23:59 | 120 | Screening and early lung cancer | E-poster session |
| 00:00 - 23:59 | 121 | Localised non-small cell lung cancer | E-poster session |
| 00:00 - 23:59 | 122 | Molecular alterations and immunology in lung cancer | E-poster session |
| 00:00 - 23:59 | 123 | Management of chronic lung conditions | E-poster session |
| 00:00 - 23:59 | 124 | Real-world data and registries of thoracic oncology | E-poster session |
| 00:00 - 23:59 | 125 | Thoracic surgery: lung cancer and infectious disease | E-poster session |
| 00:00 - 23:59 | 126 | Thoracic surgery: developments in diagnostics and outcomes | E-poster session |
| 00:00 - 23:59 | 127 | Prognostic and predictive factors: treatment of lung cancer | E-poster session |
| 00:00 - 23:59 | 128 | Biological mechanisms of lung cancer | E-poster session |
| 00:00 - 23:59 | 129 | Cardiovascular and pulmonary complications of respiratory infections | E-poster session |
| 00:00 - 23:59 | 130 | What is hot in idiopathic pulmonary fibrosis? | E-poster session |
| 00:00 - 23:59 | 131 | Natural history and management of interstitial lung diseases of known cause | E-poster session |
| 00:00 - 23:59 | 132 | Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases | E-poster session |
| 00:00 - 23:59 | 133 | Real life in the field of idiopathic pulmonary fibrosis: treatments and registries | E-poster session |
| 00:00 - 23:59 | 134 | Pulmonary embolism | E-poster session |
| 00:00 - 23:59 | 135 | Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco | E-poster session |
| 00:00 - 23:59 | 136 | Respiratory homeostasis and structural changes in disease | E-poster session |
| 00:00 - 23:59 | 137 | Rare lung diseases and lung manifestations of extrapulmonary diseases | E-poster session |
| 00:00 - 23:59 | 139 | New insights into evaluation and treatment of respiratory disease | E-poster session |
| 00:00 - 23:59 | 140 | Clinical management of lung transplant recipients | E-poster session |
| 00:00 - 23:59 | 141 | Non-invasive ventilation and nasal high flow: technical aspects and predictive scores | E-poster session |
| 00:00 - 23:59 | 142 | Effects of environmental exposures on lung pathology | E-poster session |
| 00:00 - 23:59 | 143 | Air pollution considerations | E-poster session |
| 00:00 - 23:59 | 144 | Novel findings in intensive care unit medicine: part 1 | E-poster session |
| 00:00 - 23:59 | 145 | Clinical challenges in pneumonia | E-poster session |
| 00:00 - 23:59 | 146 | New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others | E-poster session |
| 00:00 - 23:59 | 147 | Mechanism or pathways of chronic lung diseases | E-poster session |
| 00:00 - 23:59 | 148 | Imaging-based phenotyping in pulmonary disease | E-poster session |
| 00:00 - 23:59 | 149 | Screening methods and diagnostic tools for obstructive sleep apnoea | E-poster session |
| 00:00 - 23:59 | 150 | New insights into sleep apnoea: from diagnosis to treatment | E-poster session |
| 00:00 - 23:59 | 151 | Treatment of obstructive sleep apnoea and its effects | E-poster session |
| 00:00 - 23:59 | 152 | Advances in lung function practice | E-poster session |
| 00:00 - 23:59 | 153 | Exhaled biomarkers of asthma and the asthma burden | E-poster session |
| 00:00 - 23:59 | 154 | New tools for diagnosis of obstructive diseases | E-poster session |
| 00:00 - 23:59 | 155 | Monoclonal antibodies in asthma | E-poster session |
| 00:00 - 23:59 | 156 | Clinical parameters in severe asthma | E-poster session |
| 00:00 - 23:59 | 157 | Monoclonal antibodies; randomised controlled trials and real-world studies in asthma | E-poster session |
| 00:00 - 23:59 | 158 | Asthma and cough: clinical trials and pharmacological insights | E-poster session |
| 00:00 - 23:59 | 159 | Novel immunopathological mechanisms of lung disease: knowledge from translational studies | E-poster session |
| 00:00 - 23:59 | 160 | Aspergillosis and chronic lung infections | E-poster session |
| 00:00 - 23:59 | 161 | Translational science in respiratory infections | E-poster session |
| 00:00 - 23:59 | 162 | Biomarkers and characterisation of immune response in respiratory infection | E-poster session |
| 00:00 - 23:59 | 163 | Non-tuberculous mycobacterial infections and bronchiectasis | E-poster session |
| 00:00 - 23:59 | 164 | Respiratory viruses in the "pre COVID-19" era | E-poster session |
| 00:00 - 23:59 | 165 | Epidemiology and understanding of airways diseases in primary care | E-poster session |
| 00:00 - 23:59 | 166 | Pharmacological management of COPD | E-poster session |
| 00:00 - 23:59 | 167 | COPD phenotypes | E-poster session |
| 00:00 - 23:59 | 168 | A fresh look at the spectrum of symptoms in respiratory disease | E-poster session |
| 00:00 - 23:59 | 169 | COPD and the impact of comorbidities | E-poster session |
| 00:00 - 23:59 | 170 | Advance in treatments for sleep and breathing disorders and long-term adherence | E-poster session |
| 00:00 - 23:59 | 171 | Phenotyping sleep-disordered breathing and its impact on various diseases | E-poster session |
| 00:00 - 23:59 | 172 | Consequences for obstructive sleep apnoea and potential modalities for early identification | E-poster session |
| 00:00 - 23:59 | 173 | From pathophysiology to clinical consequences of sleep and breathing disorders | E-poster session |
| 00:00 - 23:59 | 174 | From respiratory physiology to diagnosis and treatment | E-poster session |
| 00:00 - 23:59 | 175 | Physiological and cellular mechanisms affecting pulmonary pathologies | E-poster session |
| 00:00 - 23:59 | 176 | Prevalence and incidence of chronic lung diseases | E-poster session |
| 00:00 - 23:59 | 177 | Advances in asthma treatment | E-poster session |
| 00:00 - 23:59 | 178 | Inhaled corticosteroids and bronchodilator studies in asthma | E-poster session |
| 00:00 - 23:59 | 179 | Clinical and functional evaluation of asthmatics | E-poster session |
| 00:00 - 23:59 | 180 | Personalised treatment of obstructive diseases | E-poster session |
| 00:00 - 23:59 | 181 | Diagnosis and management of airways disease in primary care | E-poster session |
| 00:00 - 23:59 | 182 | Intercellular communication in tissue remodelling of chronic lung diseases | E-poster session |
| 00:00 - 23:59 | 183 | Interesting clinical problems for the respiratory physician | E-poster session |
| 00:00 - 23:59 | 184 | Increase in health care utilisation of modern treatments compared with the increase in effectiveness | E-poster session |
| 00:00 - 23:59 | 185 | Experimental and laboratory studies in intensive care unit medicine | E-poster session |
| 00:00 - 23:59 | 186 | Cystic fibrosis | E-poster session |
| 00:00 - 23:59 | 187 | Transthoracic and endobronchial ultrasound | E-poster session |
| 00:00 - 23:59 | 188 | Non-tuberculous mycobacteria and latent tuberculosis infection | E-poster session |
| 00:00 - 23:59 | 189 | Neonatal and paediatric intensive care: diagnosis, management and outcomes | E-poster session |
| 00:00 - 23:59 | 190 | Conventional bronchoscopy | E-poster session |
| 00:00 - 23:59 | 191 | Endobronchial ultrasound: from rookie to pro | E-poster session |
| 00:00 - 23:59 | 192 | Tapas of respiratory physiotherapy | E-poster session |
| 00:00 - 23:59 | 193 | Asthma science: novel targets and mechanisms | E-poster session |
| 00:00 - 23:59 | 194 | Management issues in thoracic oncology | E-poster session |
| 00:00 - 23:59 | 195 | Aspects of pulmonary rehabilitation: part 1 | E-poster session |
| 00:00 - 23:59 | 196 | Phenotyping sleep-disordered breathing and its impact on various diseases | E-poster session |
| 00:00 - 23:59 | 197 | A knowledge update on respiratory muscle function, assessment and training | E-poster session |
| 00:00 - 23:59 | 198 | Burden and predictive factors for chronic lung diseases and comorbidity | E-poster session |
| 00:00 - 23:59 | 199 | Clinical issues in granulomatous lung diseases | E-poster session |
| 00:00 - 23:59 | 200 | Physiotherapy in acute respiratory care | E-poster session |
| 00:00 - 23:59 | 201 | From tobacco control policy to smoking cessation | E-poster session |
| 00:00 - 23:59 | 202 | The role of health care systems in treating tobacco dependence | E-poster session |
| 00:00 - 23:59 | 203 | Advances in lung function testing | E-poster session |
| 00:00 - 23:59 | 204 | Lower respiratory tract infections in clinical practice | E-poster session |
| 00:00 - 23:59 | 205 | Epidemiology of paediatric respiratory diseases | E-poster session |
| 00:00 - 23:59 | 206 | Thoracic surgery: malignancies | E-poster session |
| 00:00 - 23:59 | 207 | Occupational lung diseases | E-poster session |
| 00:00 - 23:59 | 208 | Occupational and environmental causes of respiratory disease | E-poster session |
| 00:00 - 23:59 | 209 | Asthma inhalers: devices and adherence studies | E-poster session |
| 00:00 - 23:59 | 210 | Lung function diagnostics | E-poster session |
| 00:00 - 23:59 | 211 | From respiratory physiology to clinical practice: exercise and respiratory muscles | E-poster session |
| 00:00 - 23:59 | 212 | Novel insights into exercise training | E-poster session |
| 00:00 - 23:59 | 213 | COPD : inhaled corticosteroids, bronchodilators and eosinophils | E-poster session |
| 00:00 - 23:59 | 214 | Organising respiratory disease management in primary care | E-poster session |
| 00:00 - 23:59 | 215 | Investigations of COPD | E-poster session |
| 00:00 - 23:59 | 216 | Scientific advances in airway pharmacology | E-poster session |
| 00:00 - 23:59 | 217 | Monitoring of inflammation in remodelling | E-poster session |
| 00:00 - 23:59 | 218 | New investigations of bronchiectasis and non-tuberculous mycobacteria | E-poster session |
| 00:00 - 23:59 | 219 | Translational therapeutic advances | E-poster session |
| 00:00 - 23:59 | 220 | Imaging evaluation of chronic lung diseases | E-poster session |
| 00:00 - 23:59 | 221 | Translational aspects of idiopathic pulmonary fibrosis | E-poster session |
| 00:00 - 23:59 | 222 | Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key | E-poster session |
| 00:00 - 23:59 | 223 | Non-invasive ventilation during acute and chronic respiratory failure: technical aspects, adherence and effects | E-poster session |
| 00:00 - 23:59 | 224 | Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation | E-poster session |
| 00:00 - 23:59 | 225 | Pulmonary embolism and beyond | E-poster session |
| 00:00 - 23:59 | 226 | Current and contemporary practices in endobronchial ultrasound | E-poster session |
| 00:00 - 23:59 | 227 | Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children | E-poster session |
| 00:00 - 23:59 | 228 | Worldwide respiratory disease across the full spectrum | E-poster session |
| 00:00 - 23:59 | 229 | From the bronchoscope to the clinic: paediatric bronchology at a glance | E-poster session |
| 00:00 - 23:59 | 230 | Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis | E-poster session |
| 00:00 - 23:59 | 231 | Pathophysiology of pulmonary hypertension | E-poster session |
| 00:00 - 23:59 | 232 | Epidemiology, diagnosis and management of pulmonary embolism | E-poster session |
| 00:00 - 23:59 | 233 | COVID-19 clinical studies | E-poster session |
| 00:00 - 23:59 | 234 | Challenge and success in a patient centered Clinical Research Collaboration | Expert view |
| 00:00 - 23:59 | 235 | Palliative care in tuberculosis | Expert view |
| 00:00 - 23:59 | 236 | Replacement of animal models in respiratory medicine | Expert view |
| 00:00 - 23:59 | 237 | Preprints: growth and evolution in the medical publishing space | Expert view |
| 00:00 - 23:59 | 238 | Lung cancer or cancer of the lung | Expert view |